Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: Results from the St. Jude Lifetime Cohort Study

Pediatric Blood and Cancer

Volumn 61, Issue 7, 2014, Pages 1270-1276

  Gurney, J G ^a,b   Kaste, S C ^a   Liu, W ^a   Srivastava, D K ^a   Chemaitilly, W ^a   Ness, K K ^a   Lanctot, J Q ^a   Ojha, R P ^a   Nottage, K A ^a   Wilson, C L ^a   Li, Z ^a   Robison, L L ^a   Hudson, M M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF MEMPHIS   (United States)

Author keywords

Cranial radiation; Epidemiology; Late effects; Osteopenia; Osteoporosis

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; ETOPOSIDE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE DENSITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CHILD; CHILDHOOD LEUKEMIA; CLINICAL EVALUATION; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG EXPOSURE; FEMALE; FOLLOW UP; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION RESPONSE; RISK ASSESSMENT; SEX DIFFERENCE; SKULL IRRADIATION;

CRANIAL RADIATION; EPIDEMIOLOGY; LATE EFFECTS; OSTEOPENIA; OSTEOPOROSIS;

ADOLESCENT; ADULT; AGE FACTORS; BONE DENSITY; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVORS;

EID: 84899693060     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25010     Document Type: Article

References (29)

1. Scheurer ME, Bondy ML, Gurney JG. Epidemiology of childhood cancer. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 6th edition. Philadelphia: Lippincott Williams & Wilkins; 2011. pp. 2-16.
2. Mostoufi-Moab S, Brodsky J, Isaacoff EJ, et al. Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation. J Clin Endocrinol Metab 2012; 97:3584-3592.
3. Arikoski P, Komulainen J, Voutilainen R, et al. Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hem Oncol 1998; 20:234-240.
4. Gunes AM, Can E, Saglam H, et al. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia. J Pediatr Hem Oncol 2010; 32:e102-e107.
5. Kaste SC, Jones-Wallace D, Rose SR, et al. Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: Frequency of occurrence and risk factors for their development. Leukemia 2001; 15:728-734.
6. Kaste SC, Rai SN, Fleming K, et al. Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2006; 46:77-87.
7. Thomas I, Donohue JE, Ness KK, et al. Bone mineral density in young adult survivors of acute lymphoblastic leukemia. Cancer 2008; 113:3248-3256.
8. Wasilewski-Masker K, Kaste SC, Hudson MM, et al. Bone mineral density deficits in survivors of childhood cancer: Long-term follow-up guidelines and review of the literature. Pediatrics 2008; 121:e705-e713.
9. Margolin JF, Rabin KR, Steuber CP, et al. Acute lymphoblastic leukemia. In: Pizzo PA, Poplack DG, editors Princples and practice of pediatric oncology, 6th edition. Philadelphia: Lippincott Williams & Wilkins; 2011. pp. 518-565.
10. Chemaitilly W, Sklar CA. Endocrine complications in long-term survivors of childhood cancers. Endocr-Relat Cancer 2010; 17:R141-R159.
11. Davies JH, Evans BA, Jones E, et al. Osteopenia, excess adiposity and hyperleptinaemia during 2 years of treatment for childhood acute lymphoblastic leukaemia without cranial irradiation. Clin Endocrinol (Oxf) 2004; 60:358-365.
12. Mandel K, Atkinson S, Barr RD, et al. Skeletal morbidity in childhood acute lymphoblastic leukemia. J Clin Oncol 2004; 22:1215-1221.
13. Crofton PM, Bone and bone turnover. Endocr Dev 2009; 15:77-100.
14. Fan C, Foster BK, Wallace WH, et al. Pathobiology and prevention of cancer chemotherapy-induced bone growth arrest, bone loss, and osteonecrosis. Curr Mol Med 2011; 11:140-151.
15. Follin C, Link K, Wiebe T, et al. Bone loss after childhood acute lymphoblastic leukaemia: An observational study with and without GH therapy. Euro J Endocrinol 2011; 164:695-703.
16. Halton JM, Atkinson SA, Fraher L, et al. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J Bone Mineral Res 1996; 11:1774-1783.
17. Halton JM, Atkinson SA, Fraher L, et al. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr 1995; 126:557-564.
18. Henderson RC, Madsen CD, Davis C, et al. Longitudinal evaluation of bone mineral density in children receiving chemotherapy. J Pediatr Hem Oncol 1998; 20:322-326.
19. Rayar MS, Nayiager T, Webber CE, et al. Predictors of bony morbidity in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2012; 59:77-82.
20. Hudson MM, Ness KK, Nolan VG, et al. Prospective medical assessment of adults surviving childhood cancer: Study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 2011; 56:825-836.
21. Ojha RP, Oancea SC, Ness KK, et al. Assessment of potential bias from non-participation in a dynamic clinical cohort of long-term childhood cancer survivors: Results from the St. Jude Lifetime Cohort Study. Pediatr Blood Cancer 2013; 60:856-864.
22. Children's Oncology Group long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. http://www.survivorshipguidelines.org/pdf/ltfuguidelines.pdf. Accessed February 4, 2014.
23. Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group long-term follow-up guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 2004; 22:4979-4990.
24. Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med 1977; 63:200-207.
25. Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiol 1999; 10:37-48.
26. Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiol 2009; 20:488-495.
27. Adams JE, Quantitative computed tomography. Euro J Radiol 2009; 71:415-424.
28. Link TM. Osteoporosis imaging: State of the art and advanced imaging. Radiol 2012; 263:3-17.
29. Pui CH, Howard SC. Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol 2008; 9:257-268.